Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ·Healthcare·Biotechnology
$8.88
-2.23%
Mkt Cap $119.71M
Analyst Ratings
Buy
9
Hold
0
Sell
0
Price Target (15 analysts)
$38.50
Range $33.00 – $44.00
Implied Upside
+333.4%
Consensus $38.50 vs current $8.88